PVLA Palvella Therapeutics, Inc.
Healthcare$113.99-1.66%ClosedMarket Cap: $1.35B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$205.15
Target (Median)
$205.00
Target Range
$143.00 - $255.00
Upside from current price: 80.0%
Rating Distribution
0 Strong Buy15 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-21 | Chardan Capital | maintain | Buy | Buy |
| 2026-05-21 | Stephens & Co. | maintain | Overweight | Overweight |
| 2026-03-31 | Chardan Capital | maintain | Buy | Buy |
| 2026-03-24 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-25 | BTIG | maintain | Buy | Buy |
| 2026-02-25 | Mizuho | maintain | Outperform | Outperform |
| 2026-02-24 | Chardan Capital | maintain | Buy | Buy |
| 2026-01-16 | BTIG | maintain | Buy | Buy |
| 2025-12-16 | TD Cowen | maintain | Buy | Buy |
| 2025-12-16 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-3.88 | $26.7K | 12 |
| Fri Dec 31 | $-6.43 | $31.4M | 10 |
| Sun Dec 31 | $-2.18 | $145.3M | 9 |
| Mon Dec 31 | $5.59 | $341.0M | 3 |